TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07746362: Helical Emitters for Treating Calcium Lesions Using Intravascular Lithotripsy With the IV-X Medical IVL System for Patients With Peripheral Artery Disease

Sponsor: IVX Medical · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 140 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07746362 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07746362 Rescue Dossier →